has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Follow Blog via Email
2018
[2] Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
2017
[3] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical …
2015
[4] A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation Curaderm BEC5
Journal of Cancer Treatment and Research, 2015
[5] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity. Relevance to BEC and Solamargine, Example of a …
2015
[6] Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
Journal of Cancer Therapy, 2015
[7] Glycoalkaloid isolation from Solanum linnaeanum berries
Fruits, 2015
[8] Chemical synthesis of saponins
2014
[9] Eggplant
Alien Gene Transfer in Crop Plants, Volume 2, 2014
[10] Synthesis and cytotoxic effect of pseudodiosgenyl saponins with thio-ring F
Bioorganic & medicinal chemistry letters, 2014
[11] Alien Gene Transfer in Crop Plants, Volume
Springer-Verlag New York, 2014
[12] Alien Gene Transfer in Crop Plants, Volume 2: Achievements and Impacts
2014
[13] Alien Gene Transfer in Crop Plants, Volume 2
Springer-Verlag New York, 2014
[14] A Review of Solasodine Rhamnosides Therapy for In-Situ Squamous Cell Carcinoma on the Penis.
British Journal of Medicine and Medical Research, 2014
[15] Alien Gene Transfer in Crop Plants, Volume 1: Innovations, Methods and Risk Assessment
Springer-Verlag New York, 2013
[16] Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
2013
[17] Topical CuradermBEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
International Journal of Clinical Medicine, 2013
[18] Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5
Journal of Cancer Therapy, 2013
[19] Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with Curaderm BEC5
2013
[20] Topical Curaderm BEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
2013